Document is current
Any future updates will be listed below
-
Authors
Zhu, Bokai https://orcid.org/0000-0003-3599-9419
Gao, Sheng https://orcid.org/0000-0002-6191-6843
Chen, Shuxiao
Wang, Yuchen
Yeung, Jason
Bai, Yunhao
Huang, Amy Y.
Yeo, Yao Yu https://orcid.org/0000-0002-7604-2296
Liao, Guanrui
Mao, Shulin
Jiang, Zhenghui G.
Rodig, Scott J.
Wong, Ka-Chun https://orcid.org/0000-0001-6062-733X
Shalek, Alex K. https://orcid.org/0000-0001-5670-8778
Nolan, Garry P. https://orcid.org/0000-0002-8862-9043
Jiang, Sizun https://orcid.org/0000-0001-6149-3142
Ma, Zongming https://orcid.org/0000-0003-2401-0177
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 14 April 2025
First Online: 22 May 2025
Competing interests
: S.J. is a cofounder of Elucidate Bio, has received speaking honoraria from Cell Signaling Technology and has received research support from Roche, Novartis and Sanofi unrelated to this work. G.P.N. received research grants from Pfizer, Vaxart, Celgene and Juno Therapeutics during the time of and unrelated to this work. G.P.N. is a cofounder of Akoya Biosciences and Ionpath; an inventor on patent US9909167; and a scientific advisory board member for Akoya Biosciences. A.K.S. reports compensation for consulting or scientific advisory board membership from Honeycomb Biotechnologies, Cellarity, Ochre Bio, Relation Therapeutics, IntrECate Biotherapeutics, Bio-Rad Laboratories, Fog Pharma, Passkey Therapeutics and Dahlia Biosciences unrelated to this work. S.J.R. receives research support from Bristol Myers Squibb and KITE/Gilead. S.J.R. is a member of the scientific advisory board of Immunitas Therapeutics. The other authors declare no competing interests.
